The Journal of cell biology · 2018
Pancreatic tumor cell metastasis is restricted by MT1-MMP binding protein MTCBP-1.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qiang Li, Cao Hong, Chen Jing, Weller Shaun G, Krueger Eugene W, Zhang Lizhi, Razidlo Gina L, McNiven Mark A
Аннотация
The process by which tumor cells mechanically invade through surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. The directed recruitment of the metalloproteinase MT1-MMP to invadopodia plays a critical role in this invasive process. Here, we provide mechanistic insight into MT1-MMP cytoplasmic tail binding protein 1 (MTCBP-1) with respect to invadopodia formation, matrix remodeling, and invasion by pancreatic tumor cells. MTCBP-1 localizes to invadopodia and interacts with MT1-MMP. We find that this interaction displaces MT1-MMP from invadopodia, thereby attenuating their number and function and reducing the capacity of tumor cells to degrade matrix. Further, we observe an inverse correlation between MTCBP-1 and MT1-MMP expression both in cultured cell lines and human pancreatic tumors. Consistently, MTCBP-1-expressing cells show decreased ability to invade in vitro and metastasize in vivo. These findings implicate MTCBP-1 as an inhibitor of the metastatic process.
Предметные рубрики MeSH
AnimalsCell Line, TumorCell MovementCell ProliferationDioxygenasesGene Expression Regulation, NeoplasticHumansIntestinal NeoplasmsIntestine, SmallLymphatic MetastasisMatrix Metalloproteinase 14MiceMice, NudeNeoplasm InvasivenessPancreasPancreatic NeoplasmsPodosomesProtein BindingRNA, Small InterferingSignal TransductionSurvival AnalysisXenograft Model Antitumor Assays